ASPHD1 and central nervous system cancer: In CCGA325, univariate regression analysis showed that age, expression level of ASPHD1, whether radiation therapy was performed, presence or absence of the 1p19q co-deletion, IDH mutation, tumor grade, and whether the tumor was recurrent were prognostic indicators in gliomas (Table 4).